ClinicalTrials.gg
RecruitingNCT06655675Updated Nov 16, 2026

Changes in Velocimetric Indices of Uterine and Umbilical Arteries Before and After Combined Spinal-epidural Analgesia in Laboring Women (PART II)

An interventional study of Ultrasound in Labor Pain, sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Recruiting at 1 site in Canada. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Started Oct 2024; still recruiting 2 years later.
Updated Nov 16, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Non-randomized
Ages
18 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 22 studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital — 3 open to participants now, 3 under way, none of them phase 3. Labor Pain · Samuel Lunenfeld Research Institute, Mount Sinai Hospital.

Planned enrollment
6th of 15
54 · median 40
Started
2024
with 1 other
No phase
15 of 22
3 open now
Registered
21st of 22
by date

Among the 22 studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital, this one is the 6th largest by planned enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2024, is one of 15 with no phase, and was the 21st registered.

Labor Pain

426 studies on the registry are indexed under Labor Pain; 76 are open to participants now.

Browse Labor Pain studies →

Open to participants now

3 of the 22 studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 31 Labor Pain studies recruiting now, 8 (26%) set no upper age limit and 23 (74%) stop at 75 or younger; 3 take children under 18; 20 take healthy volunteers.

This study: 18 Years to 50 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital, or all of them as a file.
02

Study summary

Combined spinal-epidural (CSE) for labor analgesia has been used for many years and is practiced commonly at our institution, especially when the patient requests immediate pain relief. CSE is not only beneficial for its faster onset of analgesia, but also it is favorable in relation to the need for rescue analgesia, urinary retention, and rate of instrumental delivery compared to the traditional epidural. Despite its beneficial effects, there is a risk of about 15-30% of developing abnormal fetal heart rate following CSE. This is self-resolving with minimal or no intervention. Although the cause of fetal bradycardia is not fully elucidated, variations in uterine artery blood flow after epidural analgesia are thought to be due to the interaction of numerous events related to blockade of sympathetic innervations, fluid administration, maternal hypotension, uterine vascular effects of sympathetic block, fluctuations in circulating catecholamines, and possibly the effect of opioids. Similar mechanism is thought to be a cause of fetal bradycardia after the CSE with its faster onset and superior block.

Maternal or fetal circulation during labor can be assessed using continuous-wave Doppler ultrasound to monitor maternal uterine artery (UtA) and fetal umbilical artery (UmA) velocity waveforms to detect changes in blood flow. The velocimetry indices mentioned above have been often used to assess the changes in the blood flow before and after the induction of epidural analgesia during labor in several studies. Although there are some studies regarding the effect of labor epidural analgesia using velocimetry indices, but there is currently no published study evaluating velocimetry indices of uterine and umbilical arteries before and after the induction of CSE. Thus, the aim of this study is to investigate the impact of CSE to maternal and fetal blood flow to evaluate the relationships.

The investigators hypothesize that both uterine artery and umbilical artery blood flow are reduced after the induction of CSE, which may be responsible for the occurrence of fetal bradycardia.

03

Conditions studied

  • Labor Pain

Keywords

  • combined spinal epidural (CSE)
  • fetal bradycardia
  • ultrasound
  • velocimetric index
  • hypertension
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Written
  • Term pregnant patients requesting labor analgesia
  • Singleton pregnancy
  • Term pregnant patients in active labor
  • ASA\<4
  • No evidence of fetal congenital anomalies, fetal compromise or fetal decelerations prior to CSE
  • Patients with and without diagnosed hypertensive disorders of pregnancy

Exclusion criteria

Exclusion Criteria:

  • Refusal to consent for the study
  • Known spinal deformities
  • Previous back instrumentation
  • Patients with >50 kg/㎡ due to anticipated technical challenges in Doppler studies
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
54 participants (estimated)

Study arms

  • Experimental
    Ultrasound - patients without hypertensive disorders of pregnancy

    Ultrasound will be used to measure velocimetric index of the umbilical artery.

    Device: Ultrasound

  • Experimental
    Ultrasound - patients with diagnosed hypertensive disorders of pregnancy

    Ultrasound will be used to measure velocimetric index of the umbilical artery.

    Device: Ultrasound

Interventions

  • DeviceUltrasound

    Ultrasound scan of the umbilical artery

06

What researchers measure

Primary outcomes

  1. Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at 10 minutes

    Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured 10 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 10 minutes

  2. Umbilical artery velocimetric index - pulsatility index (PI) at 10 minutes

    Umbilical artery velocimetric index - pulsatility index (PI) will be measured 10 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 10 minutes

  3. Umbilical artery velocimetric index - resistance index (RI) at 10 minutes

    Umbilical artery velocimetric index - resistance index (RI) will be measured 10 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 10 minutes

Secondary outcomes

  1. Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at baseline

    Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured prior to combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  2. Umbilical artery velocimetric index - pulsatility index (PI) at baseline

    Umbilical artery velocimetric index - pulsatility index (PI) will be measured prior to combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  3. Umbilical artery velocimetric index - resistance index (RI) at baseline

    Umbilical artery velocimetric index - resistance index (RI) will be measured prior to combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  4. Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at 5 minutes

    Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured 5 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  5. Umbilical artery velocimetric index - pulsatility index (PI) at 5 minutes

    Umbilical artery velocimetric index - pulsatility index (PI)will be measured 5 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  6. Umbilical artery velocimetric index - resistance index (RI) at 5 minutes

    Umbilical artery velocimetric index - resistance index (RI) will be measured 5 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  7. Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at 20 minutes

    Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured 20 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 20 minutes

  8. Umbilical artery velocimetric index - pulsatility index (PI) at 20 minutes

    Umbilical artery velocimetric index - pulsatility index (PI) will be measured 20 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 20 minutes

  9. Umbilical artery velocimetric index - resistance index (RI) at 20 minutes

    Umbilical artery velocimetric index - resistance index (RI) will be measured 20 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 20 minutes

  10. Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) at 30 minutes

    Umbilical artery velocimetric index - systolic/diastolic ratio (S/D) will be measured 30 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 5 minutes

  11. Umbilical artery velocimetric index - pulsatility index (PI) at 30 minutes

    Umbilical artery velocimetric index - pulsatility index (PI) will be measured 30 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 30 minutes

  12. Umbilical artery velocimetric index - resistance index (RI) at 30 minutes

    Umbilical artery velocimetric index - resistance index (RI) will be measured 30 minutes after combined spinal epidural, with the uterus in relaxed and contracted states.

    Time frame: 30 minutes

  13. Pain score at baseline - questionnaire

    Pain score - verbal numeric rating scale (0-10) prior to combined spinal epidural

    Time frame: 1 minute

  14. Pain score at 10 minutes - questionnaire

    Pain score - verbal numeric rating scale (0-10) at 10 minute after combined spinal epidural

    Time frame: 10 minutes

  15. Pain score at 30 minutes - questionnaire

    Pain score - verbal numeric rating scale (0-10) at 30 minute3 after combined spinal epidural

    Time frame: 30 minutes

  16. Sensory block level at 10 minutes

    Sensory block level at 10 minutes following combined spinal epidural

    Time frame: 10 minutes

  17. Sensory block level at 30 minutes

    Sensory block level at 30 minutes following combined spinal epidural

    Time frame: 30 minutes

  18. frequency of uterine contractions

    The number of contractions on the monitor in a 10 minute period.

    Time frame: 10 minutes

  19. Presence of prolonged hypertonic uterine contractions- questionnaire

    Presence of prolonged hypertonic uterine contractions as measured by the monitor

    Time frame: 30 minutes

  20. Hypotension: systolic blood pressure less than 80% of baseline

    Systolic blood pressure \< 80% of baseline, monitored q5 for 30 minutes following combined spinal epidural

    Time frame: 30 minutes

  21. Hypertension: systolic blood pressure greater than 120% of baseline

    Systolic blood pressure \> 120% of baseline, monitored q5 for 30 minutes following combined spinal epidural

    Time frame: 30 minutes

  22. Bradycardia: heart rate less than 70% of baseline

    Heart rate \< 70% of baseline or a heart rate \< 50bpm, monitored q5 for 30 minutes following combined spinal epidural

    Time frame: 30 minutes

  23. Desaturation: oxygen level <95%

    Oxygen level \<95%, monitored q5 for 30 minutes following combined spinal epidural

    Time frame: 30 minutes

  24. fetal heart rate at baseline

    fetal heart rate at baseline, prior to combined spinal epidural

    Time frame: 5 minutes

  25. fetal heart rate q5 min up to 30 minutes

    fetal heart rate q5 min up to 30 minutes following combined spinal epidural

    Time frame: 30 minutes

  26. presence of fetal bradycardia - questionnaire

    presence of fetal bradycardia (fetal heart rate \<110)

    Time frame: 30 minutes

  27. presence of fetal prolonged deceleration - questionnaire

    presence of fetal prolonged deceleration (fetal heart rate \<110/min lasting less than 10 minutes)

    Time frame: 30 minutes

  28. presence of fetal persistent late decelerations - questionnaire

    presence of fetal persistent late decelerations will be recorded

    Time frame: 30 minutes

  29. presence of fetal non-reassuring variable deceleration - questionnaire

    presence of fetal non-reassuring variable deceleration will be recorded

    Time frame: 30 minutes

  30. presence of fetal salutatory variability - questionnaire

    presence of fetal salutatory variability (FHR change\>25beats) will be recorded

    Time frame: 30 minutes

  31. Neonatal weight

    Neonatal weight measured after delivery in grams minutes

    Time frame: up to 24 hours

  32. Apgar score at 1 minute

    Apgar score at 1 minute

    Time frame: 1 minute

  33. Apgar score at 5 minutes

    Apgar score at 5 minutes

    Time frame: 5 minutes

  34. Mode of delivery - questionnaire

    Mode of delivery will be recorded as vaginal, assisted (forceps or vacuum), or cesarean

    Time frame: up to 24 hours

07

Study locations

1 of 1 sites recruiting
  • Mount Sinai Hospital
    Toronto, Ontario M5G1X5, Canada
    Recruiting
    • Mrinalini Balki, MD · Contactmrinalini.balki@uhn.ca · 416-586-4800
    • Javiera Vargas Zuniga, MD · Sub investigator
    • Fernanda Lanza Oliveira, MD · Sub investigator
    • Claudia Jimenez, MD · Sub investigator
    • Amir Siddiqui, MD · Sub investigator
    • Cristian Arzola, MD · Sub investigator
    • Kristi Downey, MSc · Sub investigator
    • Sebastian Hobson, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Dec 2027, 38 months after the start.

Of 192 non-industry interventional studies with no phase under Labor Pain, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 14. This study's planned 38 months is above that.

Counting every sponsor, half of 194 studies reached it within 9 months; a quarter within 5 and three quarters within 14.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Jan 2026 → Dec 2027 and completion Jan 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 17, 2024
First posted
Oct 23, 2024
StartActual
Oct 30, 2024
Primary completionEst.
Dec 2027was Jan 2026
CompletionEst.
Dec 2027was Jan 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jan 2026→Dec 2027
Nov 16, 2026
Study completion
Jan 2026→Dec 2027
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Primary completion Jan 2026→Dec 2027
    Study completion Jan 2026→Dec 2027
    + 3 other changes: verification date, oversight details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06655675
Responsible party
Sponsor
First posted
Oct 23, 2024
Start date
Oct 30, 2024
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Nov 16, 2026

Study contacts

Mrinalini Balki, MD
Contact
mrinalini.balki@uhn.ca
416-586-4800 ext. 5270
Mrinalini Balki, MD
principal investigator · MOUNT SINAI HOSPITAL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion